Table 1.
Post-COVID-19: new onset seizures without underlying pathology and in previously diagnosed, controlled epilepsy with breakthrough seizures.
| Patient Number | Age (years)s) | Constitutional symptoms and duration of it | Type of seizures | CT Chest | PCR | Laboratory data | Comorbidity disorders |
|---|---|---|---|---|---|---|---|
| 1 | Mid 50 s | Fever, fatigue, diarrhea and confusion. 3 days | Generalized seizures (GTCC) | Not available | Positive | Normal | DM |
| 2 | late 40s | Fever, fatigue, dyspnea, abdominal pain and confusion. 5 days | Generalized seizures (GTCC) | Bilateral ground-glass opacity. | Negative | Normal | No |
| 3 | Mid 80s | Fever, cough and DCL. 3 days | Generalized seizures (myoclonus) | Normal | Positive | Anemia, thrombocytopenia | HTN, DM, Hepatic. |
| 4 | late 10s | Fever, fatigue, cough, dyspnea and confusion 4 days | Generalized seizures (GTCC) complicated by serial seizures | Bilateral ground-glass opacity. | Positive | Raised liver enzymes, low PO2, anemia, leukocytosis, lymphopenia. | Epilepsy |
| 5 | late 60s | Fever, for 2 days | Generalized seizures (GTCC) | Bilateral ground-glass opacity. | Positive | Low PO2, anemia and lymphopenia. | Epilepsy, HTN and DM. |
PCR; polymerase reaction; GTCC; generalized tonic clonic seizures, HTN; hypertension, DM; diabetes Mellitus; DCL; disturbed level of consciousness; CT; computer tomography.